"Hyperaldosteronism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
Concept/Terms
Conn Syndrome- Conn Syndrome
- Syndrome, Conn
- Primary Hyperaldosteronism
- Hyperaldosteronism, Primary
- Conn's Syndrome
- Conns Syndrome
- Syndrome, Conn's
Below are MeSH descriptors whose meaning is more general than "Hyperaldosteronism".
Below are MeSH descriptors whose meaning is more specific than "Hyperaldosteronism".
This graph shows the total number of publications written about "Hyperaldosteronism" by people in Harvard Catalyst Profiles by year, and whether "Hyperaldosteronism" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 0 | 2 |
| 1997 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2004 | 3 | 1 | 4 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 4 | 0 | 4 |
| 2013 | 1 | 1 | 2 |
| 2014 | 2 | 0 | 2 |
| 2015 | 5 | 0 | 5 |
| 2016 | 1 | 0 | 1 |
| 2017 | 10 | 0 | 10 |
| 2018 | 5 | 0 | 5 |
| 2019 | 3 | 0 | 3 |
| 2020 | 10 | 0 | 10 |
| 2021 | 6 | 0 | 6 |
| 2022 | 6 | 0 | 6 |
Below are the most recent publications written about "Hyperaldosteronism" by people in Profiles.
-
Intrinsic Adrenal TWIK-Related Acid-Sensitive TASK Channel Dysfunction Produces Spontaneous Calcium Oscillations Sufficient to Drive AngII (Angiotensin II)-Unresponsive Hyperaldosteronism. Hypertension. 2022 11; 79(11):2552-2564.
-
Primary aldosteronism - a multidimensional syndrome. Nat Rev Endocrinol. 2022 11; 18(11):665-682.
-
Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism. Hypertens Res. 2022 09; 45(9):1476-1485.
-
Morphologically Normal-Appearing Adrenal Glands as a Prevalent Source of Aldosterone Production in Primary Aldosteronism. Am J Hypertens. 2022 06 16; 35(6):561-571.
-
Autonomous cortisol secretion is associated with worse arterial stiffness and vascular fibrosis in primary aldosteronism: a cross-sectional study with follow-up data. Eur J Endocrinol. 2022 Jun 07; 187(1):197-208.
-
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study. Hypertension. 2022 09; 79(9):1984-1993.
-
Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk. Eur J Endocrinol. 2022 Apr 25; 186(6):645-655.
-
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022 Apr 28; 69(4):327-359.
-
Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study. Eur J Prev Cardiol. 2022 03 11; 29(2):e85-e93.
-
Feasibility of Imaging-Guided Adrenalectomy in Young Patients With Primary Aldosteronism. Hypertension. 2022 01; 79(1):187-195.